Copyright
©The Author(s) 2022.
World J Diabetes. Nov 15, 2022; 13(11): 962-971
Published online Nov 15, 2022. doi: 10.4239/wjd.v13.i11.962
Published online Nov 15, 2022. doi: 10.4239/wjd.v13.i11.962
Table 1 Defensins play multiple roles in different diseases
Defensin | Main cellular source | Action | ||
α-defensin | HNP1 | Neutrophils; monocytes; macrophages; natural killer cells | Increase the healing rate of MRSA-infected wounds[6]; promote hemostasis[7]; r/affect the cardiovascular system[8]; inhibit thrombus formation[9] | Anti-infection and immunoregulation[23] |
HNP2-3 | Anti-tumor activity[10] | |||
HNP4 | Neutrophils | Characterize benign and malignant salivary gland tumors[11] | ||
HD5-6 | Intestinal Paneth cells | Reverse dyslipidemia and improve glucoregulatory capacity[12]; anti-tumor ability[13]; amyloid inhibitor[14] | ||
β-defensin | HBD1 | Epithelial cells; monocytes; macrophages | Anti-tumor activity[15]; potentiate osteoclastogenesis[16] | Induce the secretion of angiogenin[54]; anti-infection and immunoregulation[23] |
HBD2 | Accelerate wound healing[17]; Oncolytic activity[18]; reduce alcoholic liver injury[19] | |||
HBD3 | Accelerate wound healing[20]; induce IL-8 release and apoptosis in airway smooth muscle cells[21] | |||
HBD4 | Epithelial cells | Stimulate/suppress cancer cell proliferation and viability[22] |
- Citation: Tan ZX, Tao R, Li SC, Shen BZ, Meng LX, Zhu ZY. Role of defensins in diabetic wound healing. World J Diabetes 2022; 13(11): 962-971
- URL: https://www.wjgnet.com/1948-9358/full/v13/i11/962.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i11.962